Amgen Inc. Contracts & Agreements

376 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Award Notice
Amgen Inc.
Biotechnology
2013
Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Amgen Inc.
2024
Form of Grant of Stock Option Agreement for the Amgen Inc
Stock Agreements
Amgen Inc.
2024
Form of Restricted Stock Unit Agreement
Stock Agreements
Amgen Inc.
2024
Form of Performance Unit Agreement
Bonus & Incentive Agreements
Amgen Inc.
2024
Amgen Inc. 2009 Director Equity Incentive Program. (As Amended and Restated on October 24, 2023.)
Bonus & Incentive Agreements
Amgen Inc.
2024
Fifth Amendment to the Amgen Inc. Supplemental Retirement Plan, effective January 1, 2024
Retirement Agreements
Amgen Inc.
2024
Fourth Amendment to the Amgen Nonqualified Deferred Compensation Plan, effective January 1, 2024
Compensation Agreements
Amgen Inc.
2024
Agreement between Amgen Inc. and James Bradner, dated December 13, 2023
Amgen Inc.
2024
Second Amendment to Collaboration Agreement, entered into as of February 26, 2023, by and between Amgen Inc. and BeiGene Switzerland GmbH, and BeiGene, Ltd
Collaboration Agreements
Amgen Inc.
2023
Third Amended and Restated Credit Agreement, dated as of March 9, 2023, among Amgen Inc., the Banks therein named, Citibank, N.A., as Administrative Agent, and JPMorgan Chase...
Credit Agreements
Amgen Inc.
Biotechnology
DE
2023
Officers Certificate of the Company, dated as of March 2, 2023, including forms of the Companys 5.250% Senior Notes due 2025, 5.507% Senior Notes due 2026, 5.150% Senior Notes due...
Note Agreements
Amgen Inc.
2023
Underwriting Agreement, dated February 15, 2023, by and among the Company and Citigroup Global Markets Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC and Mizuho Securities...
Underwriting Agreements
Amgen Inc.
2023
Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Amgen Inc.
Biotechnology
NY
2023
Form of Grant of Stock Option Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2023
Form of Restricted Stock Unit Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
2023
Form of Performance Unit Agreement for the Amgen Inc. 2009 Performance Award Program
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2023
Fourth Amendment to the Amgen Inc. Supplemental Retirement Plan, effective October 20, 2022
Retirement Agreements
Amgen Inc.
Biotechnology
2023
Amendment No. 3 to Share Purchase Agreement, dated January 30, 2023, by and among BeiGene, Ltd. and Amgen Inc
Share Agreements
Amgen Inc.
2023
Term Loan Credit Agreement, dated as of December 22, 2022, by and among Amgen Inc., Citibank, N.A., as administrative agent, Bank of America, N.A., as syndication agent, Citibank,...
Loan Agreements
Amgen Inc.
2022
Transaction Agreement, dated as of December 11, 2022, by and among Amgen Inc., Pillartree Limited and Horizon Therapeutics plc
Amgen Inc.
2022
Appendix 3 to the Rule 2.7 Announcement, dated as of December 12, 2022 (Conditions Appendix)
Amgen Inc.
2022
Bridge Credit Agreement, dated as of December 12, 2022, by and among Amgen Inc., Citibank, N.A., as administrative agent, Bank of America, N.A., as syndication agent, Citibank,...
Credit Agreements
Amgen Inc.
Biotechnology
DE
2022
Amendment No. 1 to Sourcing and Supply Agreement, dated July 14, 2022, by and between Amgen USA Inc., a wholly owned subsidiary of Amgen Inc., and DaVita Inc
Supply Agreements
Amgen Inc.
2022
Underwriting Agreement, dated August 15, 2022, by and among the Company and BofA Securities, Inc., Morgan Stanley & Co. LLC, Credit Suisse Securities (USA) LLC and Deutsche Bank...
Underwriting Agreements
Amgen Inc.
2022
Officers Certificate of the Company, dated as of August 18, 2022, including forms of the Companys 4.050% Senior Notes due 2029, 4.200% Senior Notes due 2033 and 4.875% Senior...
Note Agreements
Amgen Inc.
Biotechnology
NY
2022
First Amendment to Collaboration Agreement, dated April 20, 2022, by and between Amgen Inc. and BeiGene Switzerland GmbH, and BeiGene, Ltd
Collaboration Agreements
Amgen Inc.
2022
Agreement and Plan of Merger, dated as of August 3, 2022 among ChemoCentryx, Inc., Amgen Inc. and Carnation Merger Sub, Inc
Merger Agreements
Amgen Inc.
2022
Amgen Inc. Executive Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2022
Form of ASR Agreement
Amgen Inc.
Biotechnology
NY
2022
Underwriting Agreement, dated February 17, 2022, by and among the Company and BofA Securities, Inc., Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. and Goldman Sachs &...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2022
Officers Certificate of the Company, dated as of February 22, 2022, including forms of the Companys 3.000% Senior Notes due 2029, 3.350% Senior Notes due 2032, 4.200% Senior Notes...
Note Agreements
Amgen Inc.
Biotechnology
NY
2022
Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Amgen Inc.
Biotechnology
NY
2022
Form of Grant of Stock Option Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan. (As Amended
Bonus & Incentive Agreements
Amgen Inc.
2022
Form of Restricted Stock Unit Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan. (As Amended
Bonus & Incentive Agreements
Amgen Inc.
2022
Form of Performance Unit Agreement for the Amgen Inc. 2009 Performance Award Program. (As Amended
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2022
Third Amendment to the Amgen Inc. Supplemental Retirement Plan, effective October 20, 2021
Retirement Agreements
Amgen Inc.
Biotechnology
2022
Third Amendment to the Amgen Nonqualified Deferred Compensation Plan, effective January 1, 2022
Compensation Agreements
Amgen Inc.
Biotechnology
2022
Aircraft Time Sharing Agreement, dated December 3, 2021, by and between Amgen Inc. and Robert A. Bradway
Amgen Inc.
2022
Amendment No. 8 to the Collaboration Agreement, dated November 19, 2021, by and between Amgen Inc. and AstraZeneca Collaboration Ventures, LLC
Collaboration Agreements
Amgen Inc.
2022
Amendment No. 3 to the Exclusive License and Collaboration Agreement, dated April 21, 2017, by and between Amgen Inc. and Novartis Pharma AG (portions of the exhibit have been...
Collaboration Agreements
Amgen Inc.
2022
Agreement and Plan of Merger, dated July 27, 2021, by and among Amgen Inc., Teneobio, Inc., Tuxedo Merger Sub, Inc., and Fortis Advisors LLC
Merger Agreements
Amgen Inc.
2021
Underwriting Agreement, dated August 5, 2021, by and among the Company and Citigroup Global Markets Inc., Morgan Stanley & Co. LLC, Barclays Capital Inc. and Goldman Sachs & Co....
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2021
Officers Certificate of the Company, dated as of August 9, 2021, including forms of the Companys 1.650% Senior Notes due 2028, 2.000% Senior Notes due 2032, 2.800% Senior Notes...
Note Agreements
Amgen Inc.
Biotechnology
NY
2021
Amended and Restated Collaboration Agreement, dated June 2, 2021, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
2021
Agreement and Plan of Merger, dated as of March 4, 2021, by and among Amgen Inc., Franklin Acquisition Sub, Inc. and Five Prime Therapeutics, Inc
Merger Agreements
Amgen Inc.
2021
Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Amgen Inc.
Biotechnology
NY
2021
Form of Grant of Stock Option Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan. (As Amended on December 1
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2021
Form of Restricted Stock Unit Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan. (As Amended on December
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2021
Form of Performance Unit Agreement for the Amgen Inc. 2009 Performance Award Program. (As Amended on December 1
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2021
Amgen Inc. 2009 Director Equity Incentive Program. (As Amended
Bonus & Incentive Agreements
Amgen Inc.
2021
Amendment No. 7 to the Collaboration Agreement, dated December 18, 2020, by and between Amgen Inc. and AstraZeneca Collaboration Ventures, LLC
Collaboration Agreements
Amgen Inc.
2021
Amendment No. 2 to the Collaboration Agreement, dated August 19, 2020, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
2020
Restated Amendment No. 2 to Share Purchase Agreement, dated September 24, 2020, by and among BeiGene, Ltd. and Amgen Inc
Share Agreements
Amgen Inc.
Biotechnology
NY
2020
Officers Certificate of Amgen Inc., dated as of August 17, 2020, including forms of the Companys 2.770% Senior Notes due 2053
Note Agreements
Amgen Inc.
2020
Registration Rights Agreement, dated as of August 17, 2020, by and among the Company, BofA Securities, Inc. and J.P. Morgan Securities LLC, as lead dealer managers, and BNP...
Registration Rights Agreements
Amgen Inc.
Biotechnology
NY
2020
Amendment Nos. 2 through 6 to the March 30, 2012 Collaboration Agreement between Amgen Inc. and AstraZeneca Collaboration Ventures, LLC, dated May 2 and 27 and October 2, 2016,...
Collaboration Agreements
Amgen Inc.
Biotechnology
NY
2020
Underwriting Agreement, dated as of May 4, 2020, by and among the Company and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Morgan Stanley &...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2020
Officers Certificate of the Company, dated as of May 6, 2020, including the form of the Companys 2.300% Senior Notes due 2031
Note Agreements
Amgen Inc.
Biotechnology
NY
2020
Agreement between Amgen Inc. and Peter Griffith, dated October 18, 2019
Amgen Inc.
2020
Side Letter Regarding Collaboration Agreement and Stivarga Agreement, dated February 13, 2020, by and between Onyx Pharmaceuticals, Inc. and Bayer HealthCare LLC
Collaboration Agreements
Amgen Inc.
Biotechnology
2020
Amendment No. 2 to Share Purchase Agreement, dated March 17, 2020, by and among BeiGene, Ltd. and Amgen Inc
Share Agreements
Amgen Inc.
2020
Underwriting Agreement, dated February 18, 2020, by and among the Company and Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Barclays Capital Inc. and Morgan Stanley &...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2020
Officers Certificate of the Company, dated as of February 21, 2020, including forms of the Companys 1.900% Senior Notes due 2025, 2.200% Senior Notes due 2027, 2.450% Senior Notes...
Note Agreements
Amgen Inc.
2020
Amendment No. 2 to the Asset Purchase Agreement, dated October 17, 2019, by and between Amgen Inc. and Celgene Corporation
Purchase Agreements
Amgen Inc.
Biotechnology
2020
Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Amgen Inc.
Biotechnology
NY
2020
Form of Grant of Stock Option Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan. (As Amended on December 10, 2019.)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2020
Form of Restricted Stock Unit Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan. (As Amended on December 10, 2019.)
Bonus & Incentive Agreements
Amgen Inc.
2020
Form of Performance Unit Agreement for the Amgen Inc. 2009 Performance Award Program. (As Amended on December 10, 2019.)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2020
Amgen Inc. 2009 Director Equity Incentive Program. (As Amended on December 11, 2019.)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2020
Form of Restricted Stock Unit Agreement for the Amgen Inc. 2009 Director Equity Incentive Program. (As Amended on December 11, 2019.)
Bonus & Incentive Agreements
Amgen Inc.
2020
Form of Cash-Settled Restricted Stock Unit Agreement for the Amgen 2009 Director Equity Incentive Program. (As Amended on December 11, 2019.)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2020
Second Amendment to the Amgen Inc. Supplemental Retirement Plan (As Amended and Restated effective October 23, 2019)
Retirement Agreements
Amgen Inc.
Biotechnology
2020
Second Amendment to the Amgen Nonqualified Deferred Compensation Plan (As Amended and Restated effective January 1, 2020)
Compensation Agreements
Amgen Inc.
2020
Guarantee, dated as of October 31, 2019, made by and among BeiGene, Ltd. and Amgen Inc
Guarantee Agreements
Amgen Inc.
2020
Letter Agreement, dated November 21, 2019, by and between Amgen Inc. and the parties named therein re: Treatment of Certain Product Inventory in connection with Amgens acquisition...
Amgen Inc.
Biotechnology
2020
Collaboration Agreement, dated October 31, 2019, by and between Amgen Inc. and BeiGene Switzerland GmbH, a wholly-owned subsidiary of BeiGene, Ltd
Collaboration Agreements
Amgen Inc.
Biotechnology
CA
2020
Second Amended and Restated Credit Agreement, dated as of December 12, 2019, among Amgen Inc., the Banks therein named, Citibank, N.A., as Administrative Agent, and JPMorgan Chase...
Credit Agreements
Amgen Inc.
Biotechnology
DE
2019
Amendment No. 1 to the Asset Purchase Agreement, dated August 25, 2019, by and between Amgen Inc. and Celgene Corporation
Purchase Agreements
Amgen Inc.
2019
Irrevocable Guarantee, dated August 25, 2019, by and between Amgen Inc. and Bristol-Myers Squibb Company
Guarantee Agreements
Amgen Inc.
2019
Asset Purchase Agreement, dated August 25, 2019, by and between Amgen Inc. and Celgene Corporation
Purchase Agreements
Amgen Inc.
2019
Letter Agreement, dated June 25, 2019, by and between Amgen Inc. and UCB Celltech (portions of the exhibit have been omitted because they are both (i) not material and (ii) would...
Amgen Inc.
2019
Form of Stock Option Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan. (As Amended on December 7, 2018.)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2019
Form of Restricted Stock Unit Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan. (As Amended on December 7, 2018.)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2019
Form of Performance Unit Agreement for the Amgen Inc. 2009 Performance Award Program. (As Amended on December 7, 2018.)
Bonus & Incentive Agreements
Amgen Inc.
2019
Agreement between Amgen Inc. and Murdo Gordon, dated July 25, 2018
Amgen Inc.
Biotechnology
2018
Amendment No. 1 to the Credit Agreement, dated March 9, 2018, among Amgen Inc., the Banks therein named, and Citibank, N.A., as administrative agent
Credit Agreements
Amgen Inc.
2018
Amendment No. 1 to the Collaboration Agreement, dated March 20, 2018, by and between Novartis Pharma AG and Amgen Inc. (portions of the exhibit have been omitted pursuant to a...
Collaboration Agreements
Amgen Inc.
2018
Form of Stock Option Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan. (As Amended on December 12, 2017.)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2018
Form of Restricted Stock Unit Agreement for the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan. (As Amended on December 12, 2017.)
Bonus & Incentive Agreements
Amgen Inc.
2018
Amgen Inc. 2009 Performance Award Program. (As Amended on December 12, 2017.)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2018
Form of Performance Unit Agreement for the Amgen Inc. 2009 Performance Award Program. (As Amended on December 12, 2017.)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2018
Amgen Inc. 2009 Director Equity Incentive Program. (As Amended on October 24, 2017.)
Bonus & Incentive Agreements
Amgen Inc.
2018
Form of Restricted Stock Unit Agreement for the Amgen Inc. 2009 Director Equity Incentive Program. (As Amended on October 24, 2017.)
Bonus & Incentive Agreements
Amgen Inc.
2018
Form of Cash-Settled Restricted Stock Unit Agreement for the Amgen 2009 Director Equity Incentive Program
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2018
Underwriting Agreement, dated October 31, 2017, by and among the Company and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and BNP Paribas Securities Corp., as...
Underwriting Agreements
Amgen Inc.
2017
Officers Certificate of the Company, dated as of November 2, 2017, including the form of the Companys 3.200% Senior Notes due 2027
Note Agreements
Amgen Inc.
Biotechnology
NY
2017
Exclusive License and Collaboration Agreement, dated August 28, 2015, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
Biotechnology
CA
2017
Amendment No. 1 to the Exclusive License and Collaboration Agreement, dated April 21, 2017, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
2017
Amendment No. 2 to the Exclusive License and Collaboration Agreement, dated April 21, 2017, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
2017
Collaboration Agreement, dated April 21, 2017, by and between Amgen Inc. and Novartis Pharma AG
Collaboration Agreements
Amgen Inc.
Biotechnology
CA
2017
AMGEN INC. $300,000,000SENIOR FLOATING RATE NOTES DUE 2019 $300,000,000 SENIOR FLOATING RATE NOTES DUE 2020 $700,000,000 1.900% SENIOR NOTES DUE 2019 $700,000,000 2.200% SENIOR...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2017
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
2017
Second Amendment to the Amgen Inc. Executive Incentive Plan, effective January 1, 2017
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2017
Form of Award Notice
Amgen Inc.
Biotechnology
2017
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2017
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2017
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Note Agreements
Amgen Inc.
2017
FIRST AMENDMENT TO THE AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN AS AMENDED AND RESTATED EFFECTIVE OCTOBER 16, 2013
Retirement Agreements
Amgen Inc.
2016
FIRST AMENDMENT TO THE AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN AS AMENDED AND RESTATED EFFECTIVE OCTOBER 16, 2013
Compensation Agreements
Amgen Inc.
2016
AMGEN INC. $750,000,0001.850% SENIOR NOTES DUE 2021 $750,000,000 2.250% SENIOR NOTES DUE 2023 $1,250,000,000 2.600% SENIOR NOTES DUE 2026 $1,000,000,000 4.400% SENIOR NOTES DUE...
Underwriting Agreements
Amgen Inc.
2016
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
2016
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2016
REGISTRATION RIGHTS AGREEMENT among AMGEN INC. and CREDIT SUISSE SECURITIES(USA) LLC J.P. MORGAN SECURITIES LLC CITIGROUP GLOBAL MARKETS INC. and MIZUHO SECURITIES USA INC. each...
Credit Agreements
Amgen Inc.
Biotechnology
NY
2016
Second Amendment to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan, As Amended
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2016
Form of Award Notice
Amgen Inc.
2016
Form of Award Notice
Amgen Inc.
2016
AMGEN INC. 2009 PERFORMANCE AWARD PROGRAM (Effective March 3, 2009) As Amended Through March 2, 2016 ARTICLE I PURPOSE
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2016
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2016
TERMS AND CONDITIONS
Amgen Inc.
Biotechnology
NY
2016
AMGENINC. 1,250,000,000 1.250% SENIOR NOTES DUE 2022 750,000,000 2.000% SENIOR NOTES DUE 2026 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2016
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2016
Form of Award Notice
Amgen Inc.
2015
Form of Award Notice
Amgen Inc.
2015
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
Form of Award Notice
Amgen Inc.
2015
AMGENINC. $750,000,000 2.125% SENIOR NOTES DUE 2020 $500,000,000 2.700% SENIOR NOTES DUE 2022 $1,000,000,000 3.125% SENIOR NOTES DUE 2025 $1,250,000,000 4.400% SENIOR NOTES DUE...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2015
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
2015
First Amendment to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan
Bonus & Incentive Agreements
Amgen Inc.
2015
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
Form of Award Notice
Amgen Inc.
2015
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2015
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Exchange Agreements
Amgen Inc.
2015
AMENDED ANDRESTATED CREDIT AGREEMENT Dated as of July 30, 2014 among Amgen Inc., The Borrowing Subsidiaries Herein Named, The Banks Herein Named, Citibank, N.A., asAdministrative...
Credit Agreements
Amgen Inc.
2014
AMGENINC. $850,000,000 1.250% SENIOR NOTES DUE 2017 $1,400,000,000 2.200% SENIOR NOTES DUE 2019 $1,400,000,000 3.625% SENIOR NOTES DUE 2024 $600,000,000 SENIOR FLOATING RATE NOTES...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2014
AMGEN INC. INDENTURE Dated as of May 22, 2014 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee TABLE OF CONTENTS
Indenture Agreements
Amgen Inc.
2014
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2014
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2014
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2014
AMENDMENT NO. 14 TO THE SHAREHOLDERS AGREEMENT OF KIRIN-AMGEN, INC.
Shareholders Agreements
Amgen Inc.
2014
AMGEN INC. 2009 PERFORMANCE AWARD PROGRAM (Effective March 3, 2009) As Amended Through December 13, 2013 ARTICLE I PURPOSE
Bonus & Incentive Agreements
Amgen Inc.
2014
AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN (As Amended and Restated Effective October 16, 2013) AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN (As Amended and Restated Effective October 16,...
Retirement Agreements
Amgen Inc.
2014
Amgen Nonqualified Deferred Compensation Plan As Amended and Restated Effective October 16, 2013
Compensation Agreements
Amgen Inc.
2014
AGREEMENT AND GENERAL RELEASE OF CLAIMS
Release Agreements
Amgen Inc.
Biotechnology
2014
AMENDMENT NUMBER 5 TO THE INTEGRATED FACILITIES MANAGEMENT SERVICES AGREEMENT BETWEEN JONES LANG LASALLE AMERICAS, INC. AND AMGEN INC.
Management Agreements
Amgen Inc.
2013
TERM LOAN FACILITY CREDIT AGREEMENT Dated as of September 20, 2013 among AMGEN INC., as the Borrower, BANK OFAMERICA, N.A., as Administrative Agent, The Banks Party Hereto,...
Loan Agreements
Amgen Inc.
2013
AGREEMENT AND PLAN OF MERGER by and among: ONYX PHARMACEUTICALS, INC., a Delaware corporation; AMGEN INC., a Delaware corporation; and ARENA ACQUISITION COMPANY, a Delaware...
Merger Agreements
Amgen Inc.
2013
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED BANK OF AMERICA, N.A. One Bryant Park New York, New York 10036
Amgen Inc.
Biotechnology
NY
2013
Form of Award Notice
Amgen Inc.
2013
AMGEN INC. 2009 PERFORMANCE AWARD PROGRAM (Effective March 3, 2009) As Amended Through March 6, 2013 ARTICLE I PURPOSE
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2013
Form of Award Notice
Amgen Inc.
2013
AMGEN INC. 2009 DIRECTOR EQUITY INCENTIVE PROGRAM (Effective January 1, 2013) As Amended and Restated December 13, 2012 and Subsequently Amended March 6, 2013 ARTICLE I PURPOSE
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2013
RESTRICTED STOCK UNIT AGREEMENT (Director Equity Incentive Program)
Bonus & Incentive Agreements
Amgen Inc.
2013
CONSULTING SERVICES AGREEMENT
Consulting Agreements
Amgen Inc.
Biotechnology
CA
2013
AMENDMENT NUMBER 4 TO THE INTEGRATED FACILITIES MANAGEMENT SERVICES AGREEMENT BETWEEN JONES LANG LASALLE AMERICAS, INC. AND AMGEN INC.
Management Agreements
Amgen Inc.
Biotechnology
2013
AMGEN INC. 2009 PERFORMANCE AWARD PROGRAM (Effective March 3, 2009) As Amended December 13, 2012 ARTICLE I PURPOSE
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2013
AMGEN INC. 2009 DIRECTOR EQUITY INCENTIVE PROGRAM (Effective January 1, 2013) As Amended and Restated December 13, 2012 ARTICLE I PURPOSE
Bonus & Incentive Agreements
Amgen Inc.
2013
RESTRICTED STOCK UNIT AGREEMENT (Director Equity Incentive Program)
Bonus & Incentive Agreements
Amgen Inc.
2013
FIRST AMENDMENT TO THE AMGEN INC. EXECUTIVE INCENTIVE PLAN (AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2009)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2013
AMENDMENT NO. 1 TO THE LICENSE AGREEMENT
License Agreements
Amgen Inc.
2013
AMENDMENT NO. 2 TO THE LICENSE AGREEMENT
License Agreements
Amgen Inc.
2013
Form of Award Notice
Amgen Inc.
Biotechnology
2012
FIFTH AMENDMENT TO THE AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN AS AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2009
Retirement Agreements
Amgen Inc.
Biotechnology
2012
FOURTH AMENDMENT TO THE AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN AS AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2009
Compensation Agreements
Amgen Inc.
2012
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2012
FOURTH AMENDMENT TO THE AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN AS AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2009
Retirement Agreements
Amgen Inc.
Biotechnology
2012
THIRD AMENDMENT TO THE AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN AS AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2009
Compensation Agreements
Amgen Inc.
2012
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2012
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2012
AMGEN INC. $1,250,000,000 2.125% SENIOR NOTES DUE 2017 $750,000,000 3.625% SENIOR NOTES DUE 2022 $1,000,000,000 5.375% SENIOR NOTES DUE2043 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
2012
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2012
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2012
AMGEN INC. 2009 DIRECTOR EQUITY INCENTIVE PROGRAM (Effective March 3,2009) As Amended March 15, 2012 ARTICLE I PURPOSE
Bonus & Incentive Agreements
Amgen Inc.
2012
CONSULTING SERVICES AGREEMENT
Consulting Agreements
Amgen Inc.
2012
SECOND AMENDMENT TO THE AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN AS AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2009
Retirement Agreements
Amgen Inc.
Biotechnology
2012
THIRD AMENDMENT TO THE AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN AS AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2009
Retirement Agreements
Amgen Inc.
Biotechnology
2012
SECOND AMENDMENT TO THE AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN AS AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2009
Compensation Agreements
Amgen Inc.
2012
AGREEMENT AND PLAN OF MERGER among: MICROMET, INC., a Delaware corporation; AMGEN INC., a Delaware corporation; and ARMSTRONG ACQUISITION CORP., a Delaware corporation Dated as of...
Merger Agreements
Amgen Inc.
Biotechnology
2012
CREDIT AGREEMENT Dated as of December 2, 2011 among Amgen Inc., The Borrowing Subsidiaries Herein Named, The Banks Herein Named, Citibank, N.A., as Administrative Agent, and...
Credit Agreements
Amgen Inc.
2011
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2011
AMGEN INC. $1,000,000,000 1.875% SENIOR NOTES DUE 2014 $1,000,000,000 2.50% SENIOR NOTES DUE 2016 $1,750,000,000 3.875% SENIOR NOTES DUE 2021 $2,250,000,000 5.15% SENIOR NOTES...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2011
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2011
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Exchange Agreements
Amgen Inc.
Biotechnology
2011
AMENDMENT NUMBER 3 TO THEINTEGRATED FACILITIES MANAGEMENT SERVICES AGREEMENT BETWEEN JONES LANG LASALLE AMERICAS, INC. AND AMGEN INC.
Management Agreements
Amgen Inc.
2011
EX-101 INSTANCE DOCUMENT
Amgen Inc.
2011
EX-101 INSTANCE DOCUMENT
Amgen Inc.
Biotechnology
2011
EX-101 INSTANCE DOCUMENT
Amgen Inc.
Biotechnology
CA
2011
AMGEN INC. $750,000,000 2.30% SENIOR NOTES DUE 2016 $1,000,000,000 4.10% SENIOR NOTES DUE 2021 $1,250,000,000 5.65% SENIOR NOTES DUE 2042 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
2011
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2011
EX-101 INSTANCE DOCUMENT
Amgen Inc.
Biotechnology
2011
EX-101 INSTANCE DOCUMENT
Amgen Inc.
Biotechnology
2011
EX-101 INSTANCE DOCUMENT
Amgen Inc.
2011
AMGEN INC. CHANGE OF CONTROL SEVERANCE PLAN
Change of Control Agreements
Amgen Inc.
Biotechnology
2010
EX-101 INSTANCE DOCUMENT
Amgen Inc.
Biotechnology
2010
EX-101 INSTANCE DOCUMENT
Amgen Inc.
Biotechnology
2010
EX-101 INSTANCE DOCUMENT
Amgen Inc.
Biotechnology
2010
CONSULTING SERVICES AGREEMENT
Consulting Agreements
Amgen Inc.
Biotechnology
CA
2010
AMGEN INC. $900,000,000 3.45% SENIOR NOTES DUE 2020 $600,000,000 4.95% SENIOR NOTES DUE 2041 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
2010
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2010
Form of Award Notice
Amgen Inc.
2010
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2010
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Exchange Agreements
Amgen Inc.
2010
Form of Award Notice
Amgen Inc.
2009
AMGEN INC. 2009 PERFORMANCE AWARD PROGRAM (Effective March 3, 2009) ARTICLE I PURPOSE
Bonus & Incentive Agreements
Amgen Inc.
2009
Form of Award Notice
Amgen Inc.
2009
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Exchange Agreements
Amgen Inc.
Biotechnology
DE
2009
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Exchange Agreements
Amgen Inc.
2009
AMENDMENT NO. 1 TO CREDIT AGREEMENT
Credit Agreements
Amgen Inc.
2009
AMENDMENT NO. 7 TO THE ENBREL SUPPLY AGREEMENT
Supply Agreements
Amgen Inc.
Biotechnology
2009
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2009
Form of Award Notice
Amgen Inc.
Biotechnology
2009
AMGEN INC. 2009 PERFORMANCE AWARD PROGRAM
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2009
GRANT OF NON-QUALIFIED STOCK OPTION (Director Equity Incentive Program)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2009
RESTRICTED STOCK UNIT AGREEMENT (Director Equity Incentive Program)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2009
GRANT OF NONQUALIFIED STOCK OPTION (EX-U.S.)
Stock Agreements
Amgen Inc.
2009
AMENDMENT AND RESTATEMENT OF THE AMGEN CHANGE OF CONTROL SEVERANCE PLAN
Change of Control Agreements
Amgen Inc.
Biotechnology
2009
MASTER SERVICES AGREEMENT
Services Agreements
Amgen Inc.
Biotechnology
CA
2009
INTEGRATED FACILITIES MANAGEMENT SERVICES AGREEMENT
Management Agreements
Amgen Inc.
Biotechnology
CA
2009
AMGEN INC. $1,000,000,000 5.70% SENIOR NOTES DUE 2019 $1,000,000,000 6.40% SENIOR NOTES DUE 2039 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
2009
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2009
AMGEN INC. AMENDED AND RESTATED 1999 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
WA
2008
AMGEN INC. AMENDED AND RESTATED 1999 INCENTIVE STOCK PLAN
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2008
GRANT OF STOCK OPTION AGREEMENT
Stock Agreements
Amgen Inc.
2008
AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN
Retirement Agreements
Amgen Inc.
2008
AMGEN INC. EXECUTIVE INCENTIVE PLAN
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2008
AMGEN INC. EXECUTIVE NONQUALIFIED RETIREMENT PLAN
Retirement Agreements
Amgen Inc.
Biotechnology
CA
2008
AMENDED AND RESTATED AMGEN INC. PERFORMANCE AWARD PROGRAM
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2008
AMENDMENT NO. 2 TO AMENDMENT NO. 6 TO THE ENBREL® SUPPLY AGREEMENT
Supply Agreements
Amgen Inc.
Biotechnology
2008
VARIABLE TERM ACCELERATED SHARE REPURCHASE TRANSACTION
Repurchase Agreements
Amgen Inc.
2008
AMGEN INC. $500,000,000 6.15% SENIOR NOTES DUE 2018 $500,000,000 6.90% SENIOR NOTES DUE 2038 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
2008
FIFTH AMENDMENT TO THE AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN
Retirement Agreements
Amgen Inc.
2008
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Note Agreements
Amgen Inc.
2008
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Note Agreements
Amgen Inc.
2008
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Note Agreements
Amgen Inc.
2008
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Note Agreements
Amgen Inc.
2008
GRANT OF STOCK OPTION
Stock Agreements
Amgen Inc.
2008
FIFTH AMENDMENT TO THE AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN
Compensation Agreements
Amgen Inc.
2008
AMENDMENT NO. 6 TO THE
Amgen Inc.
Biotechnology
2008
AMENDED AND RESTATED AMGEN INC. PERFORMANCE AWARD PROGRAM
Bonus & Incentive Agreements
Amgen Inc.
2007
FOURTH AMENDMENT TO THE AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN
Retirement Agreements
Amgen Inc.
Biotechnology
2007
FIRST AMENDMENT TO THE AMGEN INC. EXECUTIVE
Amgen Inc.
Biotechnology
2007
FOURTH AMENDMENT TO THE AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN
Compensation Agreements
Amgen Inc.
2007
AMENDMENT TO PROMISSORY NOTE
Note Agreements
Amgen Inc.
2007
Collaboration Agreement By and Between Amgen Inc. and Daiichi Sankyo Company, Limited
Collaboration Agreements
Amgen Inc.
Biotechnology
DE
2007
CREDIT AGREEMENT Dated as of November 2, 2007
Credit Agreements
Amgen Inc.
2007
AMENDMENT NO. 13 TO THE SHAREHOLDERS AGREEMENT OF KIRIN-AMGEN, INC.
Shareholders Agreements
Amgen Inc.
2007
PURCHASE AGREEMENT Dated May 24, 2007 between AMGEN INC.
Purchase Agreements
Amgen Inc.
2007
PURCHASE AGREEMENT
Purchase Agreements
Amgen Inc.
2007
REGISTRATION RIGHTS AGREEMENT between AMGEN INC. and MORGAN STANLEY & CO. INCORPORATED and
Registration Rights Agreements
Amgen Inc.
Biotechnology
NY
2007
THIRD AMENDMENT TO THE AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN
Retirement Agreements
Amgen Inc.
2007
EIGHTH AMENDMENT TO THE AMGEN INC. CHANGE OF CONTROL SEVERANCE PLAN
Change of Control Agreements
Amgen Inc.
Biotechnology
2007
THIRD AMENDMENT TO THE AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN
Compensation Agreements
Amgen Inc.
Biotechnology
2007
FOURTH AMENDMENT TO THE AMGEN RETIREMENT AND SAVINGS PLAN
Retirement Agreements
Amgen Inc.
2006
SEVENTH AMENDMENT TO THE AMGEN INC. CHANGE OF CONTROL SEVERANCE PLAN
Change of Control Agreements
Amgen Inc.
2006
AGREEMENT AND PLAN OF MERGER BY AND AMONG AMGEN INC., AVIATOR MERGER SUB, INC., AVIDIA, INC.
Merger Agreements
Amgen Inc.
2006
THIRD AMENDMENT TO THE AMGEN RETIREMENT AND SAVINGS PLAN
Retirement Agreements
Amgen Inc.
2006
AMGEN INC. $2,500,000,000 0.125% Convertible Senior Notes due 2011 INDENTURE Dated as of February 17, 2006 JPMORGAN CHASE BANK, N.A., Trustee
Indenture Agreements
Amgen Inc.
2006
AMGEN INC. $2,500,000,000 0.375% Convertible Senior Notes due 2013 INDENTURE Dated as of February 17, 2006 JPMORGAN CHASE BANK, N.A., Trustee
Indenture Agreements
Amgen Inc.
2006
AMENDMENT TO THE AMENDED AND RESTATED RIGHTS AGREEMENT
Amgen Inc.
2006
SECOND AMENDMENT TO THE AMGEN RETIREMENT AND SAVINGS PLAN
Retirement Agreements
Amgen Inc.
2006
FIRST AMENDMENT TO THE AMGEN RETIREMENT AND SAVINGS PLAN
Retirement Agreements
Amgen Inc.
2006
SECOND AMENDMENT TO THE AMGEN SUPPLEMENTAL RETIREMENT PLAN
Retirement Agreements
Amgen Inc.
2006
SIXTH AMENDMENT TO THE AMGEN INC. CHANGE OF CONTROL SEVERANCE PLAN
Change of Control Agreements
Amgen Inc.
2006
RESTRICTEDSTOCK PURCHASE AGREEMENT
Purchase Agreements
Amgen Inc.
2006
PURCHASE AGREEMENT
Purchase Agreements
Amgen Inc.
2006
AMGEN INC. $2,500,000,000 0.125% Convertible Senior Notes due 2011 INDENTURE Dated as of February 17, 2006 JPMORGAN CHASE BANK, N.A., Trustee CROSS REFERENCE TABLE*
Indenture Agreements
Amgen Inc.
2006
AMGEN INC. $2,500,000,000 0.375% Convertible Senior Notes due 2013 INDENTURE
Indenture Agreements
Amgen Inc.
2006
Purchase Agreement Dated February 14, 2006
Purchase Agreements
Amgen Inc.
2006
AGREEMENT AND PLAN OFMERGER Among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub,Inc. Dated as of December 14,2005
Merger Agreements
Amgen Inc.
2005
AMGEN INC.
Amgen Inc.
Biotechnology
2005
AMGEN INC.
Amgen Inc.
Biotechnology
2005
GRANT OF STOCKOPTION
Amgen Inc.
Biotechnology
2005
PERFORMANCE UNIT AGREEMENT
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2005
RESTRICTED STOCK UNIT AGREEMENT
Stock Agreements
Amgen Inc.
2005
AMGEN INC.
Amgen Inc.
Biotechnology
NY
2005
SECOND AMENDMENT TO THE AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN (As Amended and Restated Effective January 1,2005)
Compensation Agreements
Amgen Inc.
2005
Three Months Ended
Amgen Inc.
2005
AMGEN RETIREMENT AND SAVINGS PLAN (As Amended and Restated Effective January 1, 2006) TABLE OF CONTENTS
Retirement Agreements
Amgen Inc.
2005
FIRST AMENDMENT TO THE AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN AS AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2005
Compensation Agreements
Amgen Inc.
2005
FIRST AMENDMENT TO THE AMGEN SUPPLEMENTAL RETIREMENT PLAN AS AMENDED AND RESTATED EFFECTIVE JANUARY 1, 2005
Retirement Agreements
Amgen Inc.
2005
GRANT OF STOCKOPTION
Amgen Inc.
2005
Three Months Ended
Amgen Inc.
2005
FIRST AMENDMENT TO THE AMGEN INC. AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Amgen Inc.
2005
Our annual report on Form 10-K for the fiscal year ended December 31, 2004
Amgen Inc.
2005
AMGEN INC.
Amgen Inc.
2005
AMGEN INC.
Amgen Inc.
2005
AMGEN INC. AMENDEDAND RESTATED 1999 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Amgen Inc.
2005
AMENDED AND RESTATED AMGEN INC. PERFORMANCE AWARD PROGRAM (Amended and Restated Effective March 7, 2005)
Bonus & Incentive Agreements
Amgen Inc.
2005
GRANT OF STOCKOPTION
Amgen Inc.
2005
GRANT OF STOCKOPTION
Amgen Inc.
2005
PERFORMANCE UNIT AGREEMENT
Bonus & Incentive Agreements
Amgen Inc.
2005
EPOGEN (Epoetin alfa)
Amgen Inc.
2005
AMGEN INC. Liquid Yield Option Notes due 2032 (Zero Coupon Senior)
Note Agreements
Amgen Inc.
2005
FOURTH AMENDMENT TO THE AMGEN RETIREMENT AND SAVINGS PLAN (AS AMENDED AND RESTATED EFFECTIVE AS OF JANUARY 1, 2003)
Retirement Agreements
Amgen Inc.
2004
FIFTH AMENDMENT TO THE AMGEN INC. CHANGE OF CONTROL SEVERACE PLAN
Change of Control Agreements
Amgen Inc.
2004
AMGEN INC. AMENDED AND RESTATED 1991 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2004
Exhibit No
Amgen Inc.
2004
THIRD AMENDMENT TO THE AMGEN RETIREMENT AND SAVINGS PLAN (AS AMENDED AND RESTATED EFFECTIVE AS OF JANUARY 1, 2003)
Retirement Agreements
Amgen Inc.
2004
ByClark/Bardes Consulting Compensation Resource Group All Rights Reserved
Compensation Agreements
Amgen Inc.
2004
Three Months Ended
Amgen Inc.
2004
AGREEMENT AND PLAN OF MERGER BY AND AMONG AMGEN INC., ARROW ACQUISITION, LLC AND TULARIK INC.
Merger Agreements
Amgen Inc.
Biotechnology
DE
2004
STOCKHOLDER VOTING AGREEMENT BY AND BETWEEN AMGEN INC.
Voting Agreements
Amgen Inc.
2004
AMENDED AND RESTATED 1997 SPECIAL NON-OFFICER EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Amgen Inc.
2003
RESTRICTED STOCK PURCHASE AGREEMENT
Stock Agreements
Amgen Inc.
2003
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
Amgen Inc.
2003
AMENDMENT NO. 3 TO THE
Amgen Inc.
2003
THE AMGEN 1999 UK COMPANY EMPLOYEE SHARE OPTIONPLAN
Share Agreements
Amgen Inc.
2003
RESTRICTED STOCK PURCHASE AGREEMENT
Stock Agreements
Amgen Inc.
2003
AMGEN INC. AMENDED AND RESTATED 1991 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Amgen Inc.
2002
AMGEN INC. AMENDED AND RESTATED 1997 SPECIAL NON-OFFICER EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Amgen Inc.
2002
2002 SPECIAL SEVERANCE PAY PLAN FOR AMGEN EMPLOYEES
Severance Agreements
Amgen Inc.
2002
AMENDMENT NO. 2 TO THE ENBREL® SUPPLY AGREEMENT
Supply Agreements
Amgen Inc.
2002
ASSET PURCHASE AGREEMENT by and between Immunex Corporation as Seller, and Schering Aktiengesellschaft
Purchase Agreements
Amgen Inc.
2002
AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT
Purchase Agreements
Amgen Inc.
2002
AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT
Purchase Agreements
Amgen Inc.
2002
PROMISSORY NOTE
Note Agreements
Amgen Inc.
2002
GRANT OF STOCK OPTION
Stock Agreements
Amgen Inc.
2002
PROMISSORY NOTE $500,000.00
Note Agreements
Amgen Inc.
2002
Form of Permanent Global Certificate (Globalurkunde auf Dauer) of CHF 700,000,000 (700,000,000 Swiss francs) Amgen Inc. One AmgenCenter Drive Thousand Oaks, California...
Amgen Inc.
Biotechnology
CA
2016
GRANT AGREEMENT
Amgen Inc.
Biotechnology
CA
2012
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2012
Form of Award Notice
Amgen Inc.
Biotechnology
2012
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2012
AMGEN INC. 2009 PERFORMANCE AWARD PROGRAM (Effective March 3, 2009) As Amended March 14, 2012 ARTICLE I PURPOSE
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2012
24 April 2012 THE PERSONS LISTED IN PART 3 OF SCHEDULE 1 AS MN SELLERS (as defined herein) and THE PERSONS LISTED IN PART 5 OF SCHEDULE 1 AS SIHHAT SELLERS (as defined herein) and...
Amgen Inc.
Biotechnology
2012
EX-101 INSTANCE DOCUMENT
Amgen Inc.
Biotechnology
DE
2011
EX-101 INSTANCE DOCUMENT
Amgen Inc.
Biotechnology
DE
2011
EX-101 INSTANCE DOCUMENT
Amgen Inc.
Biotechnology
DE
2011
EX-101 INSTANCE DOCUMENT
Amgen Inc.
Biotechnology
2010
EX-31 SECTION 302 CERTIFICATIONS
Amgen Inc.
Biotechnology
2010
AMGEN INC.
Amgen Inc.
Biotechnology
NY
2010
OFFICERS CERTIFICATE OF
Amgen Inc.
Biotechnology
NY
2010
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2010
AMGEN INC. 2009 PERFORMANCE AWARD PROGRAM (Effective March 3, 2009) ARTICLE I PURPOSE
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2010
Form of Award Notice
Amgen Inc.
Biotechnology
DE
2009
AMGEN INC. 2009 DIRECTOR EQUITY INCENTIVE PROGRAM (Effective March 3, 2009)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2009
AMGEN INC. AMENDED AND RESTATED 1991 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2008
As Amended and Restated Effective January 1, 2009
Amgen Inc.
Biotechnology
DE
2008
AMENDMENT NO. 1 TO AMENDMENT NO. 2 TO THE
Amgen Inc.
2008
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
2008
AMENDED AND RESTATED AMGEN INC. PERFORMANCE AWARD PROGRAM
Bonus & Incentive Agreements
Amgen Inc.
2008
RECITALS:
Amgen Inc.
Biotechnology
2008
AMGEN INC. AMENDED AND RESTATED DIRECTOR EQUITY INCENTIVE PROGRAM (Amended and Restated EffectiveDecember 10, 2007) ARTICLE I PURPOSE
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2008
SECOND AMENDMENT TO THE AMGEN INC. AMENDED AND RESTATED
Amgen Inc.
Biotechnology
2008
AMGEN INC. DIRECTOR EQUITY INCENTIVE PROGRAM
Bonus & Incentive Agreements
Amgen Inc.
2007
AMENDED AND RESTATED AMGEN INC. PERFORMANCE AWARD PROGRAM
Bonus & Incentive Agreements
Amgen Inc.
2007
PERFORMANCE UNIT AGREEMENT
Bonus & Incentive Agreements
Amgen Inc.
2007
OFFICERS CERTIFICATE OF AMGEN INC.
Amgen Inc.
Biotechnology
NY
2007
Registration RightsAgreement Dated As of February 17, 2006 between
Amgen Inc.
2006
AMGEN INC.
Amgen Inc.
Biotechnology
WA
2005
AMENDED AND RESTATED AMGEN INC. PERFORMANCE AWARD PROGRAM (Amended and Restated Effective December 5, 2005)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2005
GRANT OF STOCKOPTION
Amgen Inc.
Biotechnology
DE
2005
GRANT OF STOCKOPTION
Amgen Inc.
Biotechnology
DE
2005
AMGEN INC. DIRECTOR EQUITY INCENTIVE PROGRAM (Amended and Restated Effective December 6, 2005)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2005
GRANT OF STOCKOPTION
Amgen Inc.
2005
GRANT OF STOCKOPTION
Amgen Inc.
2005
Three Months Ended
Amgen Inc.
2005
Three Months Ended
Amgen Inc.
2005
Our annual report on Form 10-K for the fiscal year ended December 31, 2004
Amgen Inc.
2005
GRANT OF STOCKOPTION
Amgen Inc.
2005
EPOGEN (Epoetin alfa)
Amgen Inc.
2005
EPOGEN (Epoetin alfa)
Amgen Inc.
2005
EPOGEN (Epoetin alfa)
Amgen Inc.
2005
FIRST AMENDMENT TO THE AMGEN INC. EXECUTIVE INCENTIVE PLAN
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
2004
AMGEN INC. PERFORMANCE AWARD PROGRAM (Amended and Restated Effective December 6, 2004)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2004
FORM OF PERFORMANCE UNIT AGREEMENT
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2004
AMGEN INC. DIRECTOR EQUITY INCENTIVE PROGRAM (Amended and Restated Effective December 6, 2004)
Bonus & Incentive Agreements
Amgen Inc.
Biotechnology
DE
2004
Exhibit No
Amgen Inc.
2004
Exhibit No
Amgen Inc.
2004
Exhibit No
Amgen Inc.
2004
Exhibit No
Amgen Inc.
2004
Three Months Ended
Amgen Inc.
2004
AMGEN INC. SUPPLEMENTAL
Amgen Inc.
2004
AMGEN INC.
Amgen Inc.
2004
Date Number of Shares for WhichRepurchase Option Shall Lapse Grant Date 34,000 First Anniversary of Grant Date 33,000 Second Anniversary of Grant Date 33,000
Amgen Inc.
2002